304 devices · GMDN 44611
Percutaneous interstitial fluid glucose monitoring systems use a small, invasively inserted electrochemical sensor to track glucose levels in the body’s interstitial fluid. These portable devices continuously provide real-time data for individuals with diabetes, helping to prevent dangerous spikes or drops in blood sugar by enabling timely therapeutic adjustments in both home and clinical settings.
These systems are typically regulated as medical devices, often requiring compliance with safety and performance standards for invasive technologies. They are generally supplied as complete kits, including sensors, transmitters, and software for data interpretation, though the display monitor itself is not part of the system and must be purchased separately.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.